Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Directorate Change

5 Dec 2019 07:00

RNS Number : 7316V
CATCo Reinsurance Opps Fund Ltd
05 December 2019
 

 

 

 

CATCo Reinsurance Opportunities Fund Ltd. (the "Company")

 

Directorate changes

 

 

To: Specialist Fund Segment, London Stock Exchange and Bermuda Stock Exchange

Date: 5 December 2019

 

 

The Board of Directors of the Company are pleased to announce the appointment of Arthur Jones as a non-executive Director of the Company with effect from the conclusion of a Board meeting of the Company held on 4 December 2019. Arthur will also chair the Company's Audit Committee.

 

Arthur is a Chartered Accountant with 35 years' experience in the financial services industry.

 

He is currently Chief Financial Officer of the Consolidated Group of Companies which provides corporate and accounting services to clients in, amongst others, the insurance and investment fund industries. He has been with the Consolidated Group of Companies since 1987. From 2005 to 2018, Arthur served on the Boards of Directors of a number of Bermuda-incorporated hedge and long-only equity funds managed by Martin Currie Group. He is a Bermuda resident.

 

At the date of this announcement, Arthur has no holding in the Ordinary shares or C shares of the Company.

 

There are no matters requiring disclosure pursuant to Listing Rule 9.6.13.

 

Arthur succeeds Alastair Barbour who, as announced on 26 February 2019, had indicated his intention to retire from the Board towards the end of 2019, and who now retires from the Board with immediate effect.

 

James Keyes, Chairman of the Company, commented:

 

"The Board is pleased to confirm Arthur's appointment while expressing our appreciation for Alastair's contribution to the Board and Audit Committee on which he has served over the last eight years. His insight, knowledge and experience have been invaluable. We wish Alastair well for the future."

 

 

For further information:

Markel CATCo Investment Management Ltd.

 

Judith Wynne

General Counsel

Telephone: +1 441 493 9005

Email: judith.wynne@markelcatco.com

 

Mark Way

Chief of Investor Marketing

Telephone: +1 441 493 9001

Email: mark.way@markelcatco.com

Numis Securities Limited

 

David Benda / Hugh Jonathan

Telephone: +44 (0) 20 7260 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGGGCPUPBGBC
Date   Source Headline
18th Dec 20241:48 pmRNSResult of Meeting
18th Dec 20247:30 amRNSSuspension - CATCo Reinsurance Opps Fund Ltd
18th Dec 20247:00 amRNS3rd Quarter Results
22nd Nov 20247:00 amRNSPartial Compulsory Redemption of Shares
18th Nov 20247:00 amRNSCirc re. Proposed winding up and notice of SGM
13th Nov 20247:00 amRNSPartial Compulsory Redemption of Shares
29th Oct 20247:00 amRNSNet Asset Value(s)
1st Oct 20242:40 pmRNSDirector/PDMR Shareholding
1st Oct 20242:40 pmRNSDirector/PDMR Shareholding
27th Sep 20243:05 pmRNSHalf-year Report
4th Sep 20247:00 amRNSNet Asset Value(s)
10th Jun 20247:00 amRNSNet Asset Value(s)
5th Jun 20242:21 pmRNSResult of AGM
24th Apr 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSNet Asset Value(s)
23rd Nov 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSNet Asset Value(s)
7th Jun 20232:00 pmRNSResult of AGM
17th May 20237:00 amRNSNet Asset Value(s)
26th Apr 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSCompulsory Acqn of Shares
21st Nov 202211:42 amRNSCompulsory Acqn of Shares - correction
21st Nov 20227:00 amRNSCompulsory Acqn of Shares
2nd Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20227:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Aug 202210:38 amRNSHolding(s) in Company
22nd Jul 20227:00 amRNSNet Asset Value(s)
14th Jul 20227:00 amRNSNet Asset Value Reporting Change
12th Jul 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSNet Asset Value(s)
1st Jun 20222:00 pmRNSResult of AGM
3rd May 202212:04 pmRNSDirectorate Change
28th Apr 20227:00 amRNSFinal Results
20th Apr 20224:25 pmRNSHolding(s) in Company
19th Apr 20221:44 pmRNSHolding(s) in Company
13th Apr 20224:41 pmRNSHolding(s) in Company
13th Apr 20222:48 pmRNSHolding(s) in Company
13th Apr 20222:46 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20227:00 amRNSScheme of arrangement - Closing Date
17th Mar 20227:00 amRNSScheme of arrangement - U.S. Bankruptcy Court
11th Mar 20224:46 pmRNSScheme of arrangement - Sanction of Schemes
10th Mar 20227:00 amRNSSOA - Chairperson’s Report on Scheme Meetings
7th Mar 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.